e-ISSN:2320-1215 p-ISSN: 2322-0112

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article Open Access

A FGFR-2 Inhibitor, Ki23057, Evaluated as a Novel VEGFR-2 Kinase Inhibitor

Abstract

The aim of this study was to clarify the ability of a FGFR-2 inhibitor, Ki23057, to inhibit the VEGFR-2 signaling pathway which was a valuable approach in the treatment of cancers. An efficient and convenient synthetic route to Ki23057 has been developed utilizing a key onepot method. Its biological activities as VEGFR-2 kinase inhibitors were evaluated by immunohistochemistry. The results exhibited that the Ki23057 has potent inhibitory activities against VEGFR-2 tyrosine kinase. Docking simulation was performed to demonstrate that Ki23057 is a potential agent for VEGFR-2 cancer therapy.

Zong-Shan Ma, Qiang-wen Fan, Hong Yan and Da-Hai Yu

To read the full article Download Full Article | Visit Full Article